Superstock Investor
Morning Briefing

Friday, January 04, 2019

Market Matters:

Futures Higher On China Rate Cut Announcement


Today's Superstock Investor Stock Scorecard:

Bristol-Myers Squibb Company (BMY)
by Superstock Investor


Bristol Myers (BMY) is buying Celgene (CELG) for $102.43. So how did our price target and upper bound do on this purchase for the acquirer? The stock is at $45.12.

Company Information

Company: Bristol-Myers Squibb Company
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Market Cap:  $98,696,500,000


  Price %Gain  
Current Price $53.28    
Price Target $53.28 0.0%  
Upper Bound $66.60 25.0%  
Lower Bound $45.29 -15.0%  

Stock data last updated 12/03/2018.

Data provided by QPI, Inc. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. QPI, Inc. is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this page, you agree not to redistribute the information found herein.


Articles That Matter:

Peoples Bank of China (PBOC) Announces Rate Cuts

This morning stocks are on fire as the PBOC made a rate cut announcement.

Rate Announcement